書誌事項
- タイトル別名
-
- Left ventricular hypertrophy in predialysis chronic kidney disease: Impact of cardiomuscular stress markers
- トウセキゼン マンセイ ジンゾウビョウ ニ オケル サシツ ヒダイ ニ カンスル シンキン バイオマーカー オ モチイタ ヒョウカ
- Impact of cardiomuscular stress markers
この論文をさがす
抄録
Left ventricular hypertrophy (LVH), which is a strong predictor of mortality in patients with endstage renal disease, is present in over 70% of patients commencing dialysis. However, only a few studies on LVH are available in patients before the start of dialysis treatment. The purpose of this study was to evaluate the prevalence and clinical correlates of LVH in patients with advanced stages of chronic kidney disease (CKD).<br>We performed a cross-sectional study of 90 patients who had renal diseases but no history of either cardiovascular diseases or arrhythmia. Circulating levels of human atrial natriuretic peptide (hANP) were also measured.<br>LVH was present in 40.0% of the study population. The prevalence of LVH tended to increase with progression of renal decline: 22.7% in stage 3, 43.6% in stage 4, and 48.3% in stage 5 (creatinine clearance>10mL/min) (p=0.15). Univariate analyses revealed that hANP and albumin were significantly different between the groups with and without LVH. Stepwise logistic regression analysis showed that hANP and albumin were selected as the independent risk factors.<br>These findings suggest that strict control of body fluid and nutrition could prevent the progression of LVH, and as a result, could attenuate the risk of cardiovascular events in CKD.
収録刊行物
-
- 日本腎臓学会誌
-
日本腎臓学会誌 49 (8), 1007-1013, 2007
社団法人 日本腎臓学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204860961536
-
- NII論文ID
- 10021273853
- 130004170824
-
- NII書誌ID
- AN10131749
-
- COI
- 1:CAS:528:DC%2BD1cXhtVKlurc%3D
-
- ISSN
- 18840728
- 03852385
-
- NDL書誌ID
- 9308759
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可